NEWS
CERENOVUS LAUNCHES NEXT GENERATION CATHETER FOR REVASCULARISATION OF PATIENTS WITH ACUTE ISCHEMIC STROKE
CERENOVUS , part of Johnson & Johnson MedTech , has announced the launch of CEREGLIDE 71 Intermediate Catheter , a next-generation intermediate catheter with TruCourse Technology indicated for the revazcularisation of patients suffering from acute ischemic stroke .
Acute ischemic strokes account for 85 % of all strokes worldwide . By utilising aspiration catheters during thrombectomy procedures , physicians can restore blood flow in the brain by directly withdrawing a blood clot or using the catheter in combination with a stent retriever . However , in nearly 50 % of cases , challenging features , such as anatomy , can impact assess to the clot , procedure time , recanalisation success and clinical outcomes .
CEREGLIDE 71 Intermediate Catheter is equipped with TruCourse Technology to increase flexibility of the device and is designed to help physicians with improved navigation and access to clots , even in challenging anatomical conditions . Part of CERENOVUS STROKE SOLUTIONS , CEREGLIDE 71 Intermediate Catheter with TruCourse provides physicians with optimal compatibility , durable delivery and reliable trackability during thrombectomy procedures .
“ In the rapidly evolving landscape of neuroendovascular stroke care , staying on the cutting edge is crucial for advancing the field and ensuring physicians have the tools to navigate complex patient anatomy ” said Fawaz Al-Mufti , MD , Interventional Neurologist , Director of the Neuroendovascular Surgery Fellowship , Westchester Medical Center / New York Medical College .
This press release contains ‘ forward-looking statements ’.
EMBR LABS ANNOUNCES STUDY RESULTS REVEALING IMPROVEMENT IN SLEEP AMONG MEN AND WOMEN
“ This is a groundbreaking study ,” said Dr Pam Peeke , study Co-author and Senior Clinical Investigator for Embr Labs , “ revealing that thermal sleep technologies like the Wave play a valuable and critical role in improving not just overall sleep quality but sleep physiology itself , to enhance people ’ s quality of life .”
Embr Labs , makers of Embr Wave , the leading temperature wearable , has announced pivotal sleep study results showing that subjects who wore the Embr Wave demonstrated a significant improvement in several measures of sleep quality including perceived sleepiness , sleep quality , reduced nocturnal resting heart rate and increased sleep efficiency . Subjects also showed improved performance in morning cognitive abilities .
A first of its kind study , Embr labs collaborated with leading human performance researchers at the West Virginia University Rockefeller Neuroscience Institute to examine the impact of the Embr Wave thermal wearable on sleep quality in men and women .
Because the Embr Wave ’ s temperature sensations work in harmony with the human body , the technology is able to provide improved sleep naturally , without drugs or side effects .
www . intelligenthealth . tech 11